Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 71526 - 71550 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	LY96	23643	upregulated	Silicon Dioxide analog results in increased expression of LY96 mRNA	8q21.11	A24195
Silicon dioxide	Approved	LY96	23643	upregulated	Silicon Dioxide results in increased expression of LY96 mRNA	8q21.11	A24196
Silicon dioxide	Approved	LYAR	55646	upregulated	Silicon Dioxide analog results in increased expression of LYAR mRNA	4p16.3	A24195
Silicon dioxide	Approved	LYN	4067	upregulated	Silicon Dioxide results in increased expression of LYN mRNA	8q12.1	A24196
Silicon dioxide	Approved	LYNX1	66004	downregulated	Silicon Dioxide analog results in decreased expression of LYNX1 mRNA	8q24.3	A24195
Silicon dioxide	Approved	LYPD1	116372	upregulated	Silicon Dioxide analog results in increased expression of LYPD1 mRNA	2q21.2	A24194 A24195
Silicon dioxide	Approved	LYPD3	27076	downregulated	Silicon Dioxide analog results in decreased expression of LYPD3 mRNA	19q13.31	A24195
Silicon dioxide	Approved	LYPD6	130574	downregulated	Silicon Dioxide analog results in decreased expression of LYPD6 mRNA	2q23.2	A24195
Silicon dioxide	Approved	LYPD8	646627	upregulated	Silicon Dioxide analog results in increased expression of LYPD8 mRNA	1q44	A24194
Silicon dioxide	Approved	LYRM9	201229	downregulated	Silicon Dioxide analog results in decreased expression of LYRM9 mRNA	17q11.2	A24195
Silicon dioxide	Approved	LYRM9	201229	downregulated	Silicon Dioxide results in decreased expression of LYRM9 mRNA	17q11.2	A24196
Silicon dioxide	Approved	M6PR	4074	upregulated	Silicon Dioxide analog results in increased expression of M6PR mRNA	12p13.31	A24195
Silicon dioxide	Approved	MAATS1	89876	upregulated	Silicon Dioxide analog results in increased expression of MAATS1 mRNA	3q13.33	A24194
Silicon dioxide	Approved	MACC1	346389	downregulated	Silicon Dioxide analog results in decreased expression of MACC1 mRNA	7p21.1	A24194
Silicon dioxide	Approved	MACROD2	140733	downregulated	Silicon Dioxide analog results in decreased expression of MACROD2 mRNA	20p12.1	A24195
Silicon dioxide	Approved	MADCAM1	8174	downregulated	Silicon Dioxide analog results in decreased expression of MADCAM1 mRNA	19p13.3	A24195
Silicon dioxide	Approved	MAFF	23764	upregulated	Silicon Dioxide analog results in increased expression of MAFF mRNA	22q13.1	A24195
Silicon dioxide	Approved	MAFF	23764	upregulated	Silicon Dioxide results in increased expression of MAFF mRNA	22q13.1	A24196
Silicon dioxide	Approved	MAGEA10	4109	downregulated	Silicon Dioxide analog results in decreased expression of MAGEA10 mRNA	Xq28	A24194
Silicon dioxide	Approved	MAGEB2	4113	upregulated	Silicon Dioxide analog results in increased expression of MAGEB2 mRNA	Xp21.2	A24195
Silicon dioxide	Approved	MAGED1	9500	downregulated	Silicon Dioxide analog results in decreased expression of MAGED1 mRNA	Xp11.22	A24195
Silicon dioxide	Approved	MAGED2	10916	downregulated	Silicon Dioxide analog results in decreased expression of MAGED2 mRNA	Xp11.21	A24195
Silicon dioxide	Approved	MAGED4B	81557	downregulated	Silicon Dioxide analog results in decreased expression of MAGED4B mRNA	Xp11.22	A24195
Silicon dioxide	Approved	MAGEL2	54551	upregulated	Silicon Dioxide analog results in increased expression of MAGEL2 mRNA	15q11.2	A24195
Silicon dioxide	Approved	MAGI1	9223	downregulated	Silicon Dioxide analog results in decreased expression of MAGI1 mRNA	3p14.1	A24195

Displaying entries 71526 - 71550 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability